Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Absci (ABSI) Research & Development (2020 - 2025)

Absci (ABSI) has disclosed Research & Development for 6 consecutive years, with $25.3 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 37.93% to $25.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $81.4 million through Dec 2025, up 27.5% year-over-year, with the annual reading at $81.4 million for FY2025, 27.5% up from the prior year.
  • Research & Development hit $25.3 million in Q4 2025 for Absci, up from $19.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $25.3 million in Q4 2025 to a low of $7.0 million in Q1 2021.
  • Historically, Research & Development has averaged $14.8 million across 5 years, with a median of $15.4 million in 2022.
  • Biggest five-year swings in Research & Development: soared 390.23% in 2021 and later dropped 28.96% in 2023.
  • Year by year, Research & Development stood at $15.8 million in 2021, then decreased by 28.23% to $11.3 million in 2022, then rose by 8.43% to $12.3 million in 2023, then soared by 49.78% to $18.4 million in 2024, then soared by 37.93% to $25.3 million in 2025.
  • Business Quant data shows Research & Development for ABSI at $25.3 million in Q4 2025, $19.2 million in Q3 2025, and $20.5 million in Q2 2025.